Novel benchtop sequencing platform

Opportunity overview

The genetics core team wishes to trial a novel bench-top sequencing platform which can scan low diversity libraries with high quality (Q30>90%; Q40>90%), a low PhiX spike, providing 2B reads per run at low cost of purchase and low cost per run (<5 GBP/Gb) and the ability to operate on small and large scale reading projects. On the basis of market analysis it is believed competition is absent for technical reasons and the awarded supplier may offer the only current ‘out of the box’ single device which fulfils this specification within the project budget. A ten day stand-still period will be observed should an economic operator who has not been identified in the market engagement wish to challenge the award, at which point the Authority may at its sole option cancel the award.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

• CPV38434540 — Biomedical equipment

Lots

• The genetics core team wishes to trial a novel bench-top sequencing platform which can scan low diversity libraries with high quality (Q30>90%; Q40>90%), a low PhiX spike, providing 2B reads per run at low cost of purchase and low cost per run (<5 GBP/Gb) and the ability to operate on small and large scale reading projects. On the basis of market analysis it is believed competition is absent for technical reasons and the awarded supplier may offer the only current ‘out of the box’ single device which fulfils this specification within the project budget. A ten day stand-still period will be observed should an economic operator who has not been identified in the market engagement wish to challenge the award, at which point the Authority may at its sole option cancel the award. Additional information: Minimum scoring applied in the sense that had the solution not met the stringent criteria of the customer it would have been rejected.Value not stated